Regency Capital Management’s Merck MRK Stock Holding History

Regency Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,209	Closed	-$89K	–	160
2021 Q1	$89K	Buy	+1,209	New	+$89.2K	0.09%	82

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Regency Capital Management's MRK Position: Q2 2021 in Review

Regency Capital Management sold out of Merck (MRK) in Q2 2021, closing a stake of 1,209 shares — an estimated $89K sold.

Regency Capital Management first reported a position in MRK in Q1 2021 and held it in 1 quarter. The position peaked at $89K in Q1 2021. 2,674 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

Regency Capital Management reported no remaining Merck position as of Q2 2021 after selling out during the quarter.
Regency Capital Management sold 1,209 Merck shares in Q2 2021, an estimated $89K.
Regency Capital Management first reported a position in Merck in Q1 2021 and held it in 1 quarter.
Regency Capital Management's Merck position peaked at $89K in Q1 2021.
2,674 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on Regency Capital Management's 13F filing for Q2 2021, filed 7 Jul 2021.